Martin Reincke, MD, PhD (he/him/his)

Department of Medicine IV, LMU Hospital, Ludwig-Maximilians-Universität München
Munich, Germany

Disclosure information not submitted.

Presentation(s):

• SAT-421 - Unmasking the Molecular Landscape of Cortisol-Producing Adenomas: An Immunohistochemistry-Guided Sequencing Approach Reveals Distinct Mutational Profiles in Overt Cushing and Mild Autonomous Cortisol Excess

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• ORF05-05 - International Real-World Study on Osilodrostat Efficacy and Safety in Adrenal Cushing Syndrome.

  Saturday, June 13, 2026
  10:15 AM - 10:30 AM CT

• SUN-019 - Impaired Work Ability and Elevated Disability in Cushing'S Syndrome: Evidence from A Multicenter German Cohort Study

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-020 - Objective Sleep and Circadian Rest-Activity Assessment in Cushing'S Syndrome using Extended Actigraphy

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-246 - Validation of A Circulating microRNA Combination for Lateralizing Primary Aldosteronism: A Multi-Center Machine Learning Study

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF31-04 - Adrenal Vein Sampling for Identifying Surgically Treatable Primary Aldosteronism: Towards an International Expert Consensus

  Sunday, June 14, 2026
  2:00 PM - 2:15 PM CT

• PL05 - Outstanding Scholarly Physician Award Presentation

  Monday, June 15, 2026
  8:00 AM - 8:15 AM CT

• MON-015 - Phase IV Study to Assess the Efficacy and Safety of Osilodrostat in Patients with Hypertension Caused by Cushing'S Syndrome with Mean Urinary Free Cortisol ≤2X the Upper Limit of Normal: LINC CARE Study Design

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• MON-031 - Soluble Alpha Klotho in Acquired Adult-Onset, and Congenital Growth Hormone Deficiency

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT